Advertisement
Canadian Journal of Cardiology

Left Atrial Appendage Closure With the Use of a WATCHMAN FLX Device in a Patient with Persistent Left Atrial Appendage Thrombus

Published:January 16, 2020DOI:https://doi.org/10.1016/j.cjca.2019.12.031
      A thrombus in the left atrial appendage (LAA) has been considered to be a contraindication to percutaneous LAA closure.

      Glikson M, Wolff R, Hindricks G, et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion [e-pub ahead of print]. Europace https://doi.org/10.1093/europace/euz258.

      Its persistence despite antithrombotic therapy (AT) or contraindication to oral anticoagulant is a challenging situation because there is no alternative for reducing the high embolic risk.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Glikson M, Wolff R, Hindricks G, et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion [e-pub ahead of print]. Europace https://doi.org/10.1093/europace/euz258.

        • Tarantini G.
        • d’Amico G.
        • Latib A.
        • et al.
        Percutaneous left atrial appendage occlusion in patients with atrial fibrillation and left appendage thrombus: feasibility, safety and clinical efficacy.
        EuroIntervention. 2018; 13: 1595-1602
        • del Furia F.
        • Ancona M.B.
        • Giannini F.
        • et al.
        First-in-man percutaneous LAA closure with an amplatzer amulet and triguard embolic protection device in a patient with LAA thrombus.
        J Invasive Cardiol. 2017; 29: E51-E52